🇺🇸 FDA
Pipeline program

Lipid-lowing Tea

DMR93-IRB-71

Phase 3 small_molecule active

Quick answer

Lipid-lowing Tea for Hyperlipidemia is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hyperlipidemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials